Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001256071-22-000002
Filing Date
2022-02-10
Accepted
2022-02-10 17:25:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G Esperion11.txt SC 13G 2059
  Complete submission text file 0001256071-22-000002.txt   3703
Mailing Address 3621 STATE STREET 695 KMS PLACE ANN ARBOR MI 48108
Business Address 3621 S STATE STREET 695KMS PLACE 734-332-0506 ANN ARBOR MI 48108
ESPERION THERAPEUTICS INC/MI (Subject) CIK: 0001066745 (see all company filings)

EIN.: 383419139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60849 | Film No.: 22615422
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PLATINUM ASSET MANAGEMENT LEVEL 8, 7 MACQUARIE PLACE SYDNEY AUSTRALIA 2000 C3 00000
Business Address C/O PLATINUM ASSET MANAGEMENT LEVEL 8, 7 MACQUARIE PLACE SYDNEY AUSTRALIA 2000 C3 00000 61292557533
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by) CIK: 0001256071 (see all company filings)

EIN.: 000000000
Type: SC 13G